Objective: To compare the efficacy and safety of a 7-day course of treatment with oral grepafloxacin, 400 mg once daily, and oral doxycycline, 100 mg twice daily, in patients with chlamydial cervicitis.
hblamydia trachomatis is the sexually-transmitted acterial pathogen with the highest incidence in the United States, causing an estimated 4 million infections each year. Around 2.6 million infections occur in women and 1.8 million in men; 250,000 of these infections occur in infants, z Up to 75% of women with uncomplicated chlamydial infection are asymptomatic, 3 making the actual number of infected individuals difficult to determine.
In some infected women, yellow or green mucopus is apparent in the endocervical canal. There may also be areas of edematous and friable cervical ectopy that bleed when manipulated. Urethral infection may also occur and, though usually asymptomatic, can be associated with dysuria and urinary frequency. 4 Infection with C. trachomatis causes considerable morbidity, particularly in women and their offspring. Chlamydial infection may cause minimal discomfort initially, allowing it to remain undetected. C. trachomatis first infects the cervix and may spread canalicularly to the endometrium, causing endometritis. Serious damage may occur when the organism ascends to the fallopian tubes, where it may manifest as acute salpingitis, an important cause of female infertility, s Chlamydial infection has also been linked to ectopic pregnancy. Maternal carriage of C. trachomatis is associated with a high incidence of illness in the offspring, including pneumonia and inclusion conjunctivitis. 6, 7 Left untreated, infected infants may harbor C. trachomatis for 1-3 years, particularly in the nasopharynx, genital tract, or rectum. In summary, a 7-day, once-daily treatment with grepafloxacin was as effective as a 7-day, twicedaily treatment with doxycycline. Grepafloxacin's activity against N. gonorrhoeae may expand its utility to patients with gonorrhea, for whom antimicrobial treatment for chlamydial infection is also recommended because of the high incidence of coinfection. It may, therefore, provide a useful alternative for the treatment of sexually transmitted endocervical infections.
